Du är här

2016-02-01

Prothena Corporation plc: Prothena to Participate in BIO CEO & Investor and Leerink Partners Healthcare Conferences

DUBLIN, Ireland, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc
(NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the
discovery, development and commercialization of novel protein
immunotherapies, today announced that members of its senior management team
will present and participate in two upcoming meetings:

* BIO CEO&Investor Conference on February 8, 2016 in New York, NY. Prothena
President and Chief Executive Officer Dale B. Schenk, PhD will present an
update on the company's business at 10:00 AM ET and participate in a
fireside chat at 1:30 PM ET.
* Leerink Partners 5th Annual Global Healthcare Conference on February 11,
2016 at 8:55 AM ET in New York, NY.

A live webcast of the presentations from both conferences can be accessed
through the investor relations section of the Company's website at
www.prothena.com. Following the live presentation, replays of the webcasts
will be available on the Company's website for at least 90 days following the
presentation date.

About Prothena

Prothena Corporation plc is a late-stage clinical biotechnology company
focused on the discovery, development and commercialization of novel protein
immunotherapy programs for the potential treatment of diseases that involve
amyloid or cell adhesion. The company is developing antibody-based product
candidates that target a number of potential indications including AL
amyloidosis (NEOD001), Parkinson's disease and other related
synucleinopathies (PRX002), and psoriasis and other inflammatory diseases
(PRX003).

For more information, please visit the company's web site at www.prothena.com.

Contacts

Investors: Tran Nguyen, CFO
650-837-8535, IR@prothena.com

Media: Ellen Rose
650-922-2405, ellen.rose@prothena.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via Globenewswire

HUG#1982416

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.